Program record · Telehealth · hormone therapy through a partner pharmacy

Gala GLP-1

Gala GLP-1 publishes no price for its hormone therapy. Its own pages describe clinician messaging, symptom check-ins, dose adjustments and free shipping of the prescription through a partner pharmacy, but no amount is stated for the medication or for the service.

1 offer · Source read Oct 23, 2026

AI Coaching Inc., d/b/a Gala GLP-1

Read from the provider's own pricing page · standard rate, no promotional pricing.

What the program charges

One row per offer. The charge stays as billed, and the monthly equivalent is derived and labeled as derived.

How this scores

Hormone replacement therapy

Form not stated

Charge
No recurring charge published
First payment
Not established
Monthly
Not established
Membership
$0/mo
Supply
Not established
Commitment
Not established
  • Medication through a partner pharmacy · No price published

How the billing works

The terms describe a monthly subscription. Because no amount for HRT is published, the record states the cadence without a figure rather than implying one.

Where the record stops

The $199 a month figure on the same site belongs to its compounded GLP-1 weight-loss medication, not to hormone therapy. Comparison listings quote $69 and $79 for HRT, but neither appears on the provider's own pages, so neither is used. The record is kept with the charge blank rather than filled from a third party.

Sourcing

The source rows behind this record

Published in full rather than collapsed. A record is only as citable as the rows behind it, including the rows that establish nothing.

6 source rows · every row dated

  • HRT price

    Not established

    The hormone-health page describes what the service includes but states no price for it. No amount is recorded.

    galaglp1.com/hormone-healthRead Oct 23, 2026

  • $199 monthly figure

    Reported

    $199 a month is the price of compounded GLP-1 weight-loss medication, a different treatment. It is not an HRT price and is not used as one.

    galaglp1.comRead Oct 23, 2026

  • Listings quoting $69 and $79

    Reported

    Two comparison listings quote $69 and $79 for HRT. Neither figure appears on the provider's own pages, so neither is published as the program's price.

    Comparison listingRead Oct 23, 2026

  • What the charge includes

    Reported

    Provider messaging while treated, symptom check-ins, dose adjustments and free shipping of the prescription. No membership fee is stated.

    galaglp1.com/hormone-healthRead Oct 23, 2026

  • Company identity

    Reported

    The terms name AI Coaching Inc., doing business as Gala GLP-1, at a Wilmington, Delaware address. Telehealth is provided by Junction and affiliate Openloop Healthcare Partners, PC.

    galaglp1.com/terms-and-conditionsRead Oct 23, 2026

  • State coverage

    Reported

    All 50 states are claimed on the homepage and in the FAQ. No list of states is published.

    galaglp1.comRead Oct 23, 2026

The terms, as published

A field with no published answer reads not established. It is never shown as a dash, because a dash is where a zero usually hides.

Hormone replacement therapy

Estradiol
Commitment
Not established
Cancellation
Cancel any time. A cancellation request must reach the provider at least 72 hours before the billing date, otherwise the next cycle is charged, and service continues to the end of that cycle.
Refunds
No refund is issued on cancellation. A refund may be issued for the unused remainder where the medical provider disqualifies the patient, and only for the most recent billing cycle.
Coverage
All 50 states claimed; no list published
Dose pricing
Not established

All 50 states are claimed on its own pages. No coverage list is published.

Commitment, cancellation and refund wording above is quoted as Gala GLP-1 published it on Oct 23, 2026. It is not a statement of a legal entitlement: auto-renewal and cancellation rules differ by state, and the provider can change its terms after that date.

Nothing here is medical advice. Whether a treatment is appropriate is a decision for a licensed clinician. These terms describe a payment, not whether a treatment is appropriate for anyone.

How this is funded

No program pays for a position here, and no outbound link carries a referral commission. That is a flag in the data rather than a sentence in the copy: if either ever changes, every page that shows this notice discloses it automatically.

Score

How complete this record is

The published total is out of 100, but 75 of those points are the same for every listed record. They are the inclusion baseline, not something this program earned. The informative figure is the detail points on top of that baseline, out of 25, earned across five published components: price level, price completeness, required fees priced, terms on record, and whether dose and coverage are stated. It measures how completely the charges are published, not clinical quality, effectiveness, safety or medical endorsement, and no editorial mark is applied.

77.0of 100 · Buyer Guide ScoreBaseline

Disclosure detail earned

2.0of 25

75 of the 77.0 is the fixed inclusion baseline shared by every listed record. The remaining 2.0 is what this record earned on the five components below.

The five components that earn those 25 points

Price level
0.0 / 7

The lowest all-in monthly equivalent the record can derive. Full marks at or below $75, none at or above $400, linear between. No marks at all where the all-in figure is withheld.

Price completeness
0.0 / 8

The share of a program's offers that carry a derivable all-in monthly figure. The heaviest single weight, because a published all-in price for every offer sold is the thing this index measures.

Required fees priced
0.0 / 4

The share of a program's offers where no required consultation, lab, membership or startup fee is left without an amount.

Terms on record
2.0 / 4

Two for stating that there is no minimum term, one for stated cancellation terms, one for a membership stated as a number. A stated lock-in earns nothing here.

Dose & coverage stated
0.0 / 2

One for stating whether the charge varies by dose, one for recording where the program ships.

Inclusion baseline
75 / 75

This score measures pricing disclosure completeness. It is not a measure of clinical quality, effectiveness or safety, and it is not a medical endorsement of any program.

See the ranked list

Criteria recorded on this program

  • Not verified

    Labs included

    The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.

    Checked Oct 23, 2026

  • Not verified

    Follow-ups included

    The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.

    Checked Oct 23, 2026

  • Verified

    No separate membership

    No membership is billed on top of the medication charge, or a stated membership is already inside it.

    Checked Oct 23, 2026

  • Not verified

    Flat across dose

    The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.

    Checked Oct 23, 2026

  • Not verified

    Month to month

    The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.

    Checked Oct 23, 2026

  • Not verified

    Compounded available

    The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.

    Checked Oct 23, 2026

  • Not verified

    FDA-approved only

    The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.

    Checked Oct 23, 2026

  • Not verified

    Ships to all 50 states

    The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.

    Checked Oct 23, 2026

Each line records what the sources established on the check date. A verified line is a finding, a verified-not-met line is the opposite finding, and a not-verified line means the source did not say. A criterion is not a ranking and not a mark of quality.

Last modified Oct 23, 2026

Report a change to this record